William S.M. Wold

11.8k total citations · 1 hit paper
208 papers, 9.8k citations indexed

About

William S.M. Wold is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, William S.M. Wold has authored 208 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Genetics, 151 papers in Molecular Biology and 57 papers in Oncology. Recurrent topics in William S.M. Wold's work include Virus-based gene therapy research (179 papers), Viral Infectious Diseases and Gene Expression in Insects (87 papers) and CAR-T cell therapy research (51 papers). William S.M. Wold is often cited by papers focused on Virus-based gene therapy research (179 papers), Viral Infectious Diseases and Gene Expression in Insects (87 papers) and CAR-T cell therapy research (51 papers). William S.M. Wold collaborates with scholars based in United States, Spain and United Kingdom. William S.M. Wold's co-authors include Ann E. Tollefson, Károly Tóth, L R Gooding, Terry Hermiston, Maurice Green, Konstantin Doronin, Jacqueline F. Spencer, Bheem M. Bhat, Péter Krajcsi and Drew L. Lichtenstein and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

William S.M. Wold

208 papers receiving 9.3k citations

Hit Papers

Adenovirus Vectors for Gene Therapy, Vaccination and Canc... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William S.M. Wold United States 54 7.4k 6.2k 2.9k 1.9k 1.5k 208 9.8k
Philip E. Branton Canada 45 3.7k 0.5× 5.1k 0.8× 2.2k 0.8× 710 0.4× 1.2k 0.8× 120 7.2k
Jeffrey M. Bergelson United States 51 6.7k 0.9× 5.1k 0.8× 2.7k 0.9× 2.8k 1.5× 1.4k 0.9× 91 10.8k
Matthew D. Weitzman United States 57 4.5k 0.6× 6.6k 1.1× 1.9k 0.7× 1.1k 0.6× 1.4k 0.9× 126 9.7k
Patrick W.K. Lee Canada 44 3.3k 0.4× 2.6k 0.4× 2.2k 0.8× 2.3k 1.2× 796 0.5× 91 6.5k
Jean Rommelaere Germany 51 5.8k 0.8× 3.2k 0.5× 2.3k 0.8× 3.0k 1.5× 940 0.6× 253 7.7k
Joe Sambrook United States 48 3.3k 0.4× 5.8k 0.9× 1.7k 0.6× 787 0.4× 1.1k 0.8× 66 9.3k
James R. Smiley Canada 42 3.9k 0.5× 5.2k 0.8× 1.6k 0.5× 1.2k 0.6× 2.9k 2.0× 99 10.2k
L R Gooding United States 43 2.9k 0.4× 3.0k 0.5× 1.4k 0.5× 893 0.5× 2.0k 1.3× 86 6.2k
François–Loïc Cosset France 73 5.6k 0.8× 6.8k 1.1× 1.6k 0.6× 2.3k 1.2× 2.2k 1.5× 285 18.5k
W. C. Russell Tanzania 30 4.1k 0.6× 4.5k 0.7× 1.3k 0.4× 1.2k 0.6× 551 0.4× 54 6.7k

Countries citing papers authored by William S.M. Wold

Since Specialization
Citations

This map shows the geographic impact of William S.M. Wold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S.M. Wold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S.M. Wold more than expected).

Fields of papers citing papers by William S.M. Wold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William S.M. Wold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S.M. Wold. The network helps show where William S.M. Wold may publish in the future.

Co-authorship network of co-authors of William S.M. Wold

This figure shows the co-authorship network connecting the top 25 collaborators of William S.M. Wold. A scholar is included among the top collaborators of William S.M. Wold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S.M. Wold. William S.M. Wold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jessup, J. Milburn, Mohamed Kabbout, Nikolay Korokhov, et al.. (2019). Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma. Human Vaccines & Immunotherapeutics. 16(3). 636–644. 9 indexed citations
3.
Wold, William S.M., et al.. (2007). Adenovirus Methods and Protocols. Methods in molecular medicine. 53 indexed citations
4.
Wold, William S.M. & Ann E. Tollefson. (2007). Adenoviruses, ad vectors, quantitation, and animal models. Humana Press eBooks. 1 indexed citations
5.
6.
Shashkova, Elena V., M Kuppuswamy, William S.M. Wold, & Konstantin Doronin. (2007). Anticancer activity of oncolytic adenovirus vector armed with IFN-α and ADP is enhanced by pharmacologically controlled expression of TRAIL. Cancer Gene Therapy. 15(2). 61–72. 39 indexed citations
7.
Thomas, Maria, Jacqueline F. Spencer, & William S.M. Wold. (2007). Use of the Syrian Hamster as an Animal Model for Oncolytic Adenovirus Vectors. Humana Press eBooks. 130. 169–184. 47 indexed citations
8.
Lichtenstein, Drew L., Károly Tóth, Konstantin Doronin, Ann E. Tollefson, & William S.M. Wold. (2004). FUNCTIONS AND MECHANISMS OF ACTION OF THE ADENOVIRUS E3 PROTEINS. International Reviews of Immunology. 23(1-2). 75–111. 144 indexed citations
9.
Ying, Baoling & William S.M. Wold. (2003). Adenovirus ADP protein (E3-11.6K), which is required for efficient cell lysis and virus release, interacts with human MAD2B. Virology. 313(1). 224–234. 24 indexed citations
10.
Tóth, Károly, Mohan Kuppuswamy, Konstantin Doronin, et al.. (2002). Construction and Characterization of E1-Minus Replication-Defective Adenovirus Vectors that Express E3 Proteins from the E1 Region. Virology. 301(1). 99–108. 7 indexed citations
11.
Kladney, Raleigh D., Ann E. Tollefson, William S.M. Wold, & Claus J. Fimmel. (2002). Upregulation of the Golgi Protein GP73 by Adenovirus Infection Requires the E1A CtBP Interaction Domain. Virology. 301(2). 236–246. 30 indexed citations
12.
Li, Ying & William S.M. Wold. (2000). Identification and Characterization of a 30K Protein (Ad4E3-30K) Encoded by the E3 Region of Human Adenovirus Type 4. Virology. 273(1). 127–138. 13 indexed citations
13.
Deryckère, François, et al.. (1995). Tumor Necrosis Factor α Increases Expression of Adenovirus E3 Proteins. Immunobiology. 193(2-4). 186–192. 13 indexed citations
14.
Wold, William S.M., Ann E. Tollefson, & Terry Hermiston. (1995). E3 Transcription Unit of Adenovirus. Current topics in microbiology and immunology. 199 ( Pt 1). 237–274. 89 indexed citations
15.
Hawkins, Lynda K. & William S.M. Wold. (1995). The E3-20.5K Membrane Protein of Subgroup B Human Adenoviruses Contains O-Linked and Complex N-Linked Oligosaccharides. Virology. 210(2). 335–344. 16 indexed citations
16.
Wold, William S.M., Terry Hermiston, & Ann E. Tollefson. (1994). Adenovirus proteins that subvert host defenses. Trends in Microbiology. 2(11). 437–443. 75 indexed citations
18.
Scaria, Abraham & William S.M. Wold. (1994). Fine-Mapping of Sequences That Suppress Splicing in the E3 Complex Transcription Unit of Adenovirus. Virology. 205(2). 406–416. 12 indexed citations
19.
Wold, William S.M. & L R Gooding. (1989). Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor.. PubMed. 6(5). 433–52. 46 indexed citations
20.
Bhat, Bheem M., Helen Brady, & William S.M. Wold. (1985). Virus Deletion Mutants That Affect a 3′ Splice Site in the E3 Transcription Unit of Adenovirus 2. Molecular and Cellular Biology. 5(9). 2405–2413. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026